Abstract: Dual function compounds are provided that may be inhibitors of histone deacetylase (HDAC) and activators of ataxia telangiectasia mutated (ATM). Pharmaceutical compositions and methods of use are also provided that utilize such compounds.
Type:
Grant
Filed:
March 3, 2015
Date of Patent:
November 7, 2017
Assignee:
Shuttle Pharmaceuticals, LLC
Inventors:
Scott Grindrod, Mira Jung, Milton Brown, Anatoly Dritschilo